Donate

BioMarin Hemophilia A Clinical Development Program Update

November 21, 2019

The following is a press release from BioMarin. 聽BioMarin is pleased to update the community regarding our gene therapy clinical trial program in hemophilia A.聽 Clinical Trial Update聽 BioMarin鈥檚 investigational gene therapy valoctocogene roxaparvovec, is currently being studied in adults with severe hemophilia A.聽 The first Phase 1/2 study was initiated in 2015 and consists […]


Sign up for E-mails, Dateline Magazine, and other ways to stay connected.